PuSH - Publikationsserver des Helmholtz Zentrums München

Hildebrandt, X.* ; Veli, Ö.* ; Hyoubi, A.* ; Zinngrebe, J.* ; Abdallah, A.T.* ; Rodefeld, J.* ; Hoffmann, A. ; Gardeweg, L.* ; Kaya, Ö.* ; Wagner, E.* ; Lindhorst, A.* ; Poggenberg, M.* ; Wang, Y.* ; Dimmler, J.* ; Schillings, J.* ; Koci, P.* ; Bonechi, F.* ; Capuccino, L.V.* ; Kiefer, C.* ; Kelepouras, K.* ; Ghosh, A.* ; Noé, F.* ; Wolfrum, C.* ; Singer, M.* ; Liccardi, G.* ; Luedde, T.* ; Yavas, A.* ; Ghallab, A.* ; Hengsler, J.G.* ; Antczak, P.* ; Gericke, M.* ; Winkels, H.* ; Blüher, M. ; Walczak, H.* ; Annibaldi, A.* ; Fischer-Posovszky, P.* ; Peltzer, N.*

Linear ubiquitination prevents lipodystrophy and obesity-associated metabolic syndrome.

Sci. Adv. 11:eadw2539 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Adipocyte hypertrophy during obesity triggers chronic inflammation, leading to metabolic disorders. However, the role of adipocyte-specific inflammatory signaling in metabolic syndrome remains unclear. The linear ubiquitin chain assembly complex, LUBAC, is an E3-ligase that generates nondegradative linear ubiquitination (Lin-Ub). LUBAC regulates NF-κB/MAPK-driven inflammation and prevents cell death triggered by immune receptors like TNF receptor-1. Here, we show that mice lacking HOIP, the Lin-E3 ligase catalytic subunit of LUBAC, in adipocytes (HoipA-KO) display lipodystrophy and heightened susceptibility to obesity-induced metabolic syndrome, particularly metabolic dysfunction-associated steatotic liver disease (MASLD). Mechanistically, loss of HOIP attenuates TNF-induced NF-κB activation and promotes cell death in human adipocytes. Inhibiting caspase-8-mediated cell death is sufficient to prevent lipodystrophy and MASLD in HoipA-KO obese mice. HOIP expression in adipose tissue positively correlates with metabolic fitness in obese individuals. Overall, our findings reveal a fundamental developmental role for Lin-Ub in adipocytes by mitigating cell death-driven adipose tissue inflammation and protecting against obesity-related metabolic syndrome.
Impact Factor
Scopus SNIP
Altmetric
12.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Lipodystrophy; Adipose-tissue Inflammation; Insulin-resistance; Targeted Activation; Enrichment Analysis; Cell-death; Ikk-beta; Apoptosis; Fat; Mice; Expression
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2375-2548
e-ISSN 2375-2548
Zeitschrift Science Advances
Quellenangaben Band: 11, Heft: 38, Seiten: , Artikelnummer: eadw2539 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington, DC [u.a.]
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-506501-001
Förderungen Ministry of Science, Research and Arts Baden-Wuerttemberg (Margarete von Wrangell-Programm)
Deutsche Forschungsgemeinschaft
Jurgen Manchot Stiftung Foundation
Center of Mollecular Medicine of Cologne
Deutsches Zentrum fur Diabetesforschung
Scopus ID 105016673726
PubMed ID 40961178
Erfassungsdatum 2025-10-21